Allogeneic HCT feasible in older patients with myelodysplastic syndrome

Allogeneic hematopoietic cell transplantation (allo-HCT) is feasible in older patients with myelodysplastic syndrome (MDS), according to a study published online June 26 in the European Journal of Haematology.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup